Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I7P6
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016874 | ligase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 57 | 61 | PF00656 | 0.414 |
CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.435 |
DOC_CDC14_PxL_1 | 66 | 74 | PF14671 | 0.368 |
DOC_PP1_RVXF_1 | 159 | 165 | PF00149 | 0.312 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.309 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.509 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.412 |
DOC_WW_Pin1_4 | 36 | 41 | PF00397 | 0.417 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.420 |
LIG_14-3-3_CanoR_1 | 107 | 116 | PF00244 | 0.479 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.330 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.353 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.425 |
LIG_LIR_Gen_1 | 117 | 127 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.350 |
LIG_LYPXL_L_2 | 149 | 158 | PF13949 | 0.316 |
LIG_LYPXL_S_1 | 149 | 153 | PF13949 | 0.348 |
LIG_LYPXL_yS_3 | 150 | 153 | PF13949 | 0.415 |
LIG_SH2_GRB2like | 157 | 160 | PF00017 | 0.317 |
LIG_SH2_STAT3 | 157 | 160 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.325 |
LIG_SUMO_SIM_par_1 | 4 | 12 | PF11976 | 0.472 |
MOD_DYRK1A_RPxSP_1 | 36 | 40 | PF00069 | 0.382 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.395 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.465 |
MOD_GlcNHglycan | 60 | 64 | PF01048 | 0.380 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.391 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.374 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.546 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.439 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.571 |
MOD_NEK2_2 | 151 | 156 | PF00069 | 0.295 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.348 |
MOD_PKA_1 | 134 | 140 | PF00069 | 0.469 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.409 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.382 |
MOD_ProDKin_1 | 36 | 42 | PF00069 | 0.419 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.425 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.347 |
TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.486 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEH7 | Leptomonas seymouri | 83% | 100% |
A0A0S4J9U7 | Bodo saltans | 63% | 99% |
A0A1X0NUN3 | Trypanosomatidae | 67% | 100% |
A0A3Q8IGM3 | Leishmania donovani | 100% | 100% |
A0A422N080 | Trypanosoma rangeli | 70% | 100% |
A4HK60 | Leishmania braziliensis | 93% | 100% |
D0A9U8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
E9B2K3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4Q5K3 | Leishmania major | 99% | 100% |
V5AQT2 | Trypanosoma cruzi | 70% | 68% |